Report urges companies to hunt for more value from their patents
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more
Brian Tenner sits down with IAM to discuss the company’s win and future strategy
GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation
In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.
01 July 2021
Insurance giant, which recently announced a $400m IP fund, says it has a strong pipeline of lending deals in the works
17 June 2021
Recent recordals show the electric car maker has cut a deal with Panasonic, assimilated a large portfolio of solar rights and gained assets via M&A deals
16 June 2021
Up to 30,000 individual grants are at risk as the country’s highest court decides whether to retroactively apply a landmark ruling it handed down last week
11 May 2021
Landmark move suggests realignment in America’s domestic and international healthcare IP stance
06 May 2021
Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress
04 May 2021
A ruling handed down by the US Tax Court this week suggests generics can deduct legal fees for ANDA litigation
29 April 2021
If the experience of NantWorks’ IP chief Mark Kokes is anything to go by, leading strategists from other sectors can make a splash in pharma and biotech
24 April 2021
Yesterday’s hearing in Minerva Surgical v Hologic is likely to have big implications for transactions and assignee-assignor disputes
22 April 2021
Life sciences innovators set to benefit from landmark Eliquis decision
15 April 2021
Unlock unlimited access to all IAM content